| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,601,300 | 1,718,200 | 1,653,000 | 1,712,600 | | Cost of Revenue | 515,500 | 556,000 | 541,700 | 533,200 | | | Gross Profit | 1,085,800 | 1,162,200 | 1,111,300 | 1,179,400 | | | Operating Expenses | | Research Development | 80,400 | 99,800 | 92,600 | 90,300 | | Selling General and Administrative | 616,600 | 647,600 | 644,800 | 678,200 | | Non Recurring | 9,600 | 4,500 | 30,400 |
-
| | Others |
-
| 40,000 | (20,600) | 10,000 | | | | Total Operating Expenses |
-
| 791,900 | 747,200 |
-
| | | | Operating Income or Loss | 379,200 | 370,300 | 364,100 | 400,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,200 | 9,800 | 11,900 | 19,200 | | Earnings Before Interest And Taxes | 386,400 | 380,100 | 376,000 | 420,100 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 386,400 | 380,100 | 376,000 | 420,100 | | Income Tax Expense | 105,300 | 102,400 | 102,200 | 114,300 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 281,100 | 277,700 | 273,800 | 305,800 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 281,100 | 277,700 | 273,800 | 305,800 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $281,100 | $277,700 | $273,800 | $305,800 |
|
0.45% Nasdaq 
0.20%
Income Statement
